High caffeine levels associated with weight loss and type 2 diabetes risk: BMJ

Published Date: 17 Mar 2023

UK: A recent study published in BMJ Medicine found that more caffeine in the blood can reduce the risk of type 2 diabetes and obesity. more...

Read Full News

Latest News

Health Round: Most Air Pollution Exposure in U.S. Pregnancies Is From Wildfires, Study Says

We also share a report from cardiologists that suggests you might (or might not) want to check your waist and hip measurements, and a laboratory study with some encouraging...

Prader-Willi Experts Flag Safety Risks Linked to Rare Disease Drug

Experts in Prader-Willi Syndrome on Tuesday raised safety concerns over Neurocrine's drug Vykat XR, citing serious adverse events reported ⁠in patients with the rare genetic...

Duration and Age Tied to Different Complication Risks in T1D

In patients with childhood onset T1D, a longer diabetes duration is mainly linked to a higher risk for retinopathy, and older age more strongly predicts albuminuria after over 30 years of follow up.

Weekly Somapacitan Effective and Safe in Turner Syndrome

Once-weekly somapacitan is as effective as daily growth hormone in promoting linear growth among treatment-naive girls with Turner syndrome, offering a suitable alternative treatment.

Role-Play as Patients Helps Docs Manage Diabetes Better

A 1-week, on-site role-play-based program in which physicians simulate patient experiences leads to better A1c control in patients with type 2 diabetes at 6 and 12 months.

Low-Carb Diets: Modest Wins for Weight, Blood Sugar

Cutting carbs may help adults with overweight or obesity achieve modest weight loss and improve some metabolic markers, but the benefits appear limited and don’t increase with stricter restriction.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Todays Updates

SBRT vs IMRT: Better for Bowel Symptoms, Not Cancer Control

For men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.

Can Electronic PRO Monitoring Ease Fatigue in Breast Cancer?

Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.

FDA Approves Iberdomide Combo for Multiple Myeloma

Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.

Latest News

We also share a report from cardiologists that suggests you might (or might not) want to check your waist and hip measurements, and a laboratory study with some encouraging...

Experts in Prader-Willi Syndrome on Tuesday raised safety concerns over Neurocrine's drug Vykat XR, citing serious adverse events reported ⁠in patients with the rare genetic...

In patients with childhood onset T1D, a longer diabetes duration is mainly linked to a higher risk for retinopathy, and older age more strongly predicts albuminuria after over 30 years of follow up.

Once-weekly somapacitan is as effective as daily growth hormone in promoting linear growth among treatment-naive girls with Turner syndrome, offering a suitable alternative treatment.

A 1-week, on-site role-play-based program in which physicians simulate patient experiences leads to better A1c control in patients with type 2 diabetes at 6 and 12 months.

Cutting carbs may help adults with overweight or obesity achieve modest weight loss and improve some metabolic markers, but the benefits appear limited and don’t increase with stricter restriction.

News All Time

First Once-Weekly Basal Insulin Now Available in the US

The FDA approved Novo Nordisk's Awiqli for adults with type 2 diabetes in March 2026.

Manufacturing Issues Prevent GEP-NET Radioligand Approval

Maker says it's committed to resolving the issues and remains confident in ¹⁷⁷Lu-edotreotide.

Amazon Pharmacy Offers Weight-loss Drugs for $50 a Month Through Medicare Bridge Program

Amazon's pharmacy unit said on Thursday it would offer weight-loss drugs to eligible Medicare beneficiaries for $50 a ⁠month through a new federal program created to expand...

Semaglutide: A New Treatment Option for AUD?

Although it missed the primary endpoint, oral semaglutide significantly reduced heavy drinking days and several other alcohol-related outcomes in a phase 2 trial.

Automated Thoracic CT Scan Can Reliably Measure Bone Density

An automated framework for trabecular volumetric bone mineral density extraction from thoracic CT scans demonstrates reproducibility across various technical acquisition scenarios.

Immune Marker Curbs Starch Cravings After Bariatric Surgery

Changes in anti-inflammatory cytokine IL-10 levels can independently predict shifts in starchy food preferences after laparoscopic sleeve gastrectomy.

ATG Shows Real-Word Value for Early Type 1 Diabetes

The safety profile and C-peptide data support antithymocyte globulin as an alternative to teplizumab.

Baseline PET-CT Scans May Flag High-Risk B-Cell Lymphoma

A composite radiomic score derived from baseline imaging features may predict survival outcomes in patients with primary mediastinal B-cell lymphoma.

Gastroparesis Surgery Linked to Better Glycemic Control

A large EHR study finds reduced insulin use and lower rates of diabetes-related complications among patients undergoing surgery for diabetic gastroparesis than among those who do not.

BMI or Waist Circumference Rivals Lancet Obesity Definition

Obesity can be diagnosed just as accurately using BMI or waist circumference criteria as with The Lancet Commission’s more complex definition.

Bitter Hop Extract Boosts Fat Loss, Spares Muscle

A bitter hop extract helped adults with obesity shed nearly 5 kg of fat in 24 weeks — without losing muscle. Some had GI side effects

Obesity Linked to Asparaginase Toxicity Risk in ALL

Obesity and older age are linked to an increased risk for severe asparaginase-associated toxicities during induction therapy for young patients with acute lymphoblastic leukemia.

Higher Childhood BMI Linked to Fewer Births in Adulthood

Women with overweight or obesity BMI trajectories during childhood are less likely to give birth in adulthood than those with average BMI trajectories.

Simple Markers Identify Precancerous Gastric Lesions

Noninvasive measures of belly fat and insulin resistance independently predict the presence and severity of intestinal metaplasia.

Fad or Fact: Prebiotic Soda Is Great for Gut Health

Prebiotic sodas are marketed as a gut- and calorie-friendly alternative to regular soda, but the health claims are often misleading.

Alcohol, Obesity, and Diabetes Risk: It’s Complicated

A longitudinal study found that obesity and high alcohol consumption consistently increased diabetes risk, whereas low-to-moderate alcohol consumption added little risk in people without obesity.

Recommended News For You

In cancer survivors, loneliness is associated with a higher risk of death.

Nuclear missile workers are contracting cancer: They blame the bases

An individual state lost $4.02 billion due to untreated mental illness.

AI could help improve early detection of interval breast cancers

Taking the "Boob Bus"; Reluctance to Grant Prior Authorization; Alcohol's Carcinogenic Potential?

MRI Enhancement Predicts Breast Cancer in BRCA Carriers

Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer

Recommended Articles For You

Bone Marrow Niche Regeneration Strategies in Hematology 

AI and Optical Advances: Evolving Blood Cell Morphology Observation in Hematology 

The Digital Revolution in Oncology - How Software, AI, and Data are Reshaping Cancer Care by 2025 

Case Study: The Role of JAK Inhibitors in Myeloproliferative Disorders 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Don't Call It Cancer; Clues to 'Exceptional' Responses; More Predictions for 2025

2.

The September 2018 issue of Medical Bulletin.

3.

US to Loosen Marijuana Rules in Major Shift for $47 Billion Industry

4.

For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.

5.

CAR-T Induces Deep, Durable Remission in Smoldering Myeloma

1.

Tumor Microenvironment Reprogramming Through Stromal Modulation

2.

The benefits and risks of taking fludrocortisone for adrenal insufficiency 

3.

AI and Optical Advances: Evolving Blood Cell Morphology Observation in Hematology

4.

Advanced Advances in Oncology for Healthcare Excellence

5.

Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

1.

The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion

2.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VI

5.

The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot